Hydrocortisone cardioprotection in ischaemia/reperfusion injury involves antioxidant mechanisms

被引:2
|
作者
Escudero, Daiana S. [1 ,2 ]
Fantinelli, Juliana C. [1 ,3 ]
Martinez, Valeria R. [1 ,3 ]
Arbelaez, Luisa F. Gonzalez [1 ,3 ]
Amarillo, Maria E. [1 ,4 ]
Perez, Nestor G. [1 ,3 ]
Diaz, Romina G. [1 ,3 ]
机构
[1] Univ Nacl La Plata, Fac Ciencias Med Plata, Ctr Invest Cardiovasc Dr Horacio E Cingolani, La Plata, Argentina
[2] Established Investigator Comis Invest Cient CIC, Buenos Aires, Argentina
[3] Established Investigators Consejo Nacl Invest Cien, Buenos Aires, Argentina
[4] Agencia Nacl Promoc Cient & Tecnol Agencia I D i, Buenos Aires, Argentina
关键词
AKT; cardioprotection; glucocorticoids; myocardial infarction; NHE1; oxidative stress; ISCHEMIA-REPERFUSION INJURY; CARDIAC-SURGERY; HEART; CORTICOSTEROIDS; PREVENTION; GLUCOCORTICOIDS; ASSOCIATION; INHIBITION; ACTIVATION; APOPTOSIS;
D O I
10.1111/eci.14172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundGlucocorticoid (GR) and mineralocorticoid (MR) receptors are highly expressed in cardiac tissue, and both can be activated by corticosteroids. MR activation, in acute myocardial infarction (AMI), worsens cardiac function, and increase NHE activity contributing to the deleterious process. In contrast, effects of GR activation are not fully understood, probably because of the controversial scenario generated by using different doses or potencies of corticosteroids.AimsWe tested the hypothesis that an acute dose of hydrocortisone (HC), a low-potency glucocorticoid, in a murine model of AMI could be cardioprotective by regulating NHE1 activity, leading to a decrease in oxidative stress.Materials and MethodsIsolated hearts from Wistar rats were subjected to regional ischemic protocol. HC (10 nmol/L) was added to the perfusate during early reperfusion. Infarct size and oxidative stress were determined. Isolated papillary muscles from non-infarcted hearts were used to evaluate HC effect on sodium-proton exchanger 1 (NHE1) by analysing intracellular pH recovery from acute transient acidosis.ResultsHC treatment decreased infarct size, improved cardiac mechanics, reduced oxidative stress after AMI, while restoring the decreased level of the pro-fusion mitochondrial protein MFN-2. Co-treatment with the GR-blocker Mifepristone avoided these effects. HC reduced NHE1 activity by increasing the NHE1 pro-inhibiting Ser648 phosphorylation site and its upstream kinase AKT. HC restored the decreased AKT phosphorylation and anti-apoptotic BCL-2 protein expression detected after AMI.ConclusionsOur results provide the first evidence that acute HC treatment during early reperfusion induces cardioprotection against AMI, associated with a non-genomic HC-triggered NHE1 inhibition by AKT and antioxidant action that might involves mitochondrial dynamics improvement. Possible nongenomic protective pathways induced by acute HC treatment during I/R. GR activation preserves MFN-2 decreasing oxidative stress. Through GR-independent pathway, HC promotes an AKT-mediated inhibitory NHE1 phosphorylation (Ser 648), preventing sodium-triggered calcium overload and thus MPTP opening leading to cardioprotection.image
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Cellular mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury.
    Nossuli, TO
    Hayward, R
    Scalia, R
    Lefer, AM
    FASEB JOURNAL, 1998, 12 (05): : A1113 - A1113
  • [32] Cardioprotection by liposome-conjugated sialyl Lewis(x)-oligosaccharide in myocardial ischaemia and reperfusion injury
    Murohara, T
    Margiotta, J
    Phillips, LM
    Paulson, JC
    DeFrees, S
    Zalipsky, S
    Guo, LSS
    Lefer, AM
    CARDIOVASCULAR RESEARCH, 1995, 30 (06) : 965 - 974
  • [33] Monophosphoryl lipid A provides biphasic cardioprotection against ischaemia-reperfusion injury in rat hearts
    Yamashita, N
    Hoshida, S
    Otsu, K
    Taniguchi, N
    Kuzuya, T
    Hori, M
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (02) : 412 - 418
  • [34] Remote limb ischaemic conditioning produces cardioprotection in rats with testicular ischaemia-reperfusion injury
    Yan, Zhibing
    Du, Lei
    Liu, Quanhua
    Zhou, Leng
    Hu, Zhaoyang
    EXPERIMENTAL PHYSIOLOGY, 2021, 106 (11) : 2223 - 2234
  • [35] Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin
    Rodrigo, Ramon
    Retamal, Catalina
    Schupper, Denisse
    Vergara-Hernandez, Diego
    Saha, Sarmistha
    Profumo, Elisabetta
    Buttari, Brigitta
    Saso, Luciano
    MOLECULES, 2022, 27 (08):
  • [36] Mechanisms mediating the cardioprotective effects of rapamycin in ischaemia-reperfusion injury
    Liu, You-Bin
    Yu, Bo
    Li, Shu-Feng
    Fan, Ying
    Han, Wei
    Yu, Jiang-Bo
    Wang, Zheng
    Li, Xiang-Lu
    Sun, Li-Ping
    Yang, Shu-Sen
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (01): : 77 - 83
  • [37] Vascular ischaemia and reperfusion injury
    Eltzschig, HK
    Collard, CD
    BRITISH MEDICAL BULLETIN, 2004, 70 (01) : 71 - 86
  • [38] Ischaemia/reperfusion injury and inflammation
    Fuller, BJ
    TRANSPLANTATION, 2000, 69 (03) : 327 - 328
  • [39] Liver ischaemia and reperfusion injury
    Busuttil, R.
    BRITISH JOURNAL OF SURGERY, 2007, 94 (07) : 787 - 788
  • [40] Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury
    Akbas, H
    Ozden, M
    Kanko, M
    Maral, H
    Bulbul, S
    Yavuz, S
    Ozker, E
    Berki, T
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 (05) : 528 - 536